Font Size

SCREEN

Profile

Direction

Menu Style

In Brief
  1. ISIRV Journal: For the last 6 years, another year-on-year increase - IRV Journal impact factor now 4.38
  2. WHO issues emergency use listing for eighth COVID-19 vaccine
  3. Updated WHO guidance on therapeutic use of corticosteroids for COVID-19
  4. OPTIONS XI ABSTRACT DEADLINE 25 MAY - Submit your abstract now
  5. RSV2022 ABSTRACT DEADLINE 25 MAY - submit your abstract now
isirv options xi banner

Return to Menu

Prevention and Treatment of RVI's: Antivirals, Traditional Therapies and Host-Directed Interventions

Call for Abstracts

The Scientific Advisory Committee invites abstracts for oral or poster presentations in the following areas ~

Emerging Viral Threats
RVI Epidemiology and Impact
RVI Diagnosis and Diagnostics
Antivirals, Immunomodulators and Traditional Therapies for RVIs
Pathogenesis of SARI
Clinical Features of Influenza, RSV and other RVIs
Community-Acquired Pneumonia and RVIs
Vaccines and Preventive Strategies
The Yu Garden
                                                                                                                                               The Yu Garden

Abstract submission is now closed. Notification of acceptance will be e-mailed by 7th April 2017.

Abstract modification: Abstracts may be modified prior to the cut-off date of the 31 March 2017. To do this first access
your isirv member page by logging into your isirv account, then click your abstract reference in the 'Conferences' section.
This will open the submission module and, if still possible, 'Modify your abstract' will be an available option in the left menu.